Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Research output: Contribution to journalJournal articleResearchpeer-review

Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

Original languageDanish
Article numberV01170037
JournalUgeskrift for Laeger
Volume179
Issue number22
Pages (from-to)2-6
Number of pages5
ISSN0041-5782
Publication statusPublished - 14 Aug 2017

    Research areas

  • English Abstract, Journal Article

ID: 184209021